We have analyzed the expression of immunological markers before and after anti-PD-1 treatment in a patient with a long recurrent history of HNSCC and spontaneous immunity to the NY-ESO-1 antigen. This evidence concerns the gene PDCD1 and head and neck squamous cell carcinoma.